Due to problems in sales Glaxosmithkline (GSK www.gsk.com) has announced that the intend to reduce their workforce by 100. In their offices in Currabinniny, Co. Cork they employ over 500 people working on the Tykerb, breast cancer drugs. Up to 100 pharmaceutical jobs will be lost. The site director Finbar Whyte, said that it was not a reflection on the performance by the employees, rather it was due to lack of sales.
The news does come with the shock factor as a little under a year ago GSK announced 150 new pharmaceutical jobs in Cork and then just under a year later they are getting rid of them. It will be interesting to keep an eye on the other big pharma companies who are also dealing with a similar down turn.